S H Kelkar and Company Limited Stock

Equities

SHK

INE500L01026

Specialty Chemicals

Market Closed - NSE India S.E. 07:43:49 2024-04-19 am EDT 5-day change 1st Jan Change
202.3 INR +0.15% Intraday chart for S H Kelkar and Company Limited -2.29% +39.09%
Sales 2022 15.64B 188M Sales 2023 16.87B 202M Capitalization 13.45B 161M
Net income 2022 1.49B 17.83M Net income 2023 612M 7.34M EV / Sales 2022 1.61 x
Net Debt 2022 5.79B 69.45M Net Debt 2023 5.32B 63.9M EV / Sales 2023 1.11 x
P/E ratio 2022
13.3 x
P/E ratio 2023
22 x
Employees 557
Yield 2022
0.52%
Yield 2023
2.01%
Free-Float 29.5%
More Fundamentals * Assessed data
Dynamic Chart
S H Kelkar and Company Limited Approves Interim Dividend for the Financial Year 2023-24, Payable No Later Than April 28, 2024 CI
S H Kelkar and Company Limited Announces Incorporation of Wholly Owned Subsidiary - Keva Usa Inc CI
Transcript : S H Kelkar and Company Limited, Q3 2024 Earnings Call, Feb 08, 2024
S H Kelkar and Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : S H Kelkar and Company Limited, Q2 2024 Earnings Call, Nov 06, 2023
S H Kelkar and Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
SH Kelkar Invests Additional 5 Million Euros in Wholly-Owned Subsidiary MT
S H Kelkar Unit Completes Acquisiton of Balance Stake in Netherlands-based Provier Beheer MT
Transcript : S H Kelkar and Company Limited, Q1 2024 Earnings Call, Aug 08, 2023
S H Kelkar and Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
S H Kelkar and Company Seeks Acquisitions CI
Transcript : S H Kelkar and Company Limited, Q4 2023 Earnings Call, Jun 01, 2023
S H Kelkar and Company Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
S H Kelkar and Company Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
S H Kelkar and Company Limited Recommends Final Dividend for the Financial Year 2022-23 CI
More news

Latest transcript on S H Kelkar and Company Limited

1 day+0.15%
1 week-2.29%
Current month-1.56%
1 month+10.58%
3 months+17.92%
6 months+34.06%
Current year+39.09%
More quotes
1 week
196.30
Extreme 196.3
214.00
1 month
193.10
Extreme 193.1
219.60
Current year
144.65
Extreme 144.65
226.35
1 year
102.70
Extreme 102.7
226.35
3 years
81.65
Extreme 81.65
226.35
5 years
47.50
Extreme 47.5
226.35
10 years
47.50
Extreme 47.5
362.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 09-12-31
Director of Finance/CFO - 21-11-14
Chairman 81 80-12-31
Members of the board TitleAgeSince
Director/Board Member 63 22-05-24
Director/Board Member 73 22-02-19
Chief Executive Officer 50 09-12-31
More insiders
Date Price Change Volume
24-04-19 202.3 +0.15% 287,491
24-04-18 202 -0.79% 266,634
24-04-16 203.6 +0.57% 132,080
24-04-15 202.4 -2.22% 347,398
24-04-12 207 -2.61% 263,676

Delayed Quote NSE India S.E., April 19, 2024 at 07:43 am EDT

More quotes
S H Kelkar and Company Limited is an India-based fragrance and flavour company. The Company is engaged in the business of manufacturing, supplying and exporting of fragrances, flavours and aroma ingredients. The Company's segments include Fragrance and Flavours. Fragrance segment includes fragrance products that are used by various consumption categories, such as personal wash, soaps and detergents, sanitizers, home cleaners, fabric care and fine fragrances, among others. Flavours segment includes flavour products that are used as raw material by producers of baked goods, dairy products, beverages and pharmaceutical products. Its natural actives product portfolio includes Camisooth, AloeHeal, Glycibright, OleoKare and Puniblock. It offers products under SHK, Cobra, Auris, Wheel, Three Birds and Keva brands. It provides a range of research and testing services in the areas of biotechnology and microbiology research, cosmetic research, cosmetic biotechnology and custom synthesis.
More about the company